GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Samsung Biologics Co 207940.KS · KRW

Health Care · Life Sciences Tools & Services · KRX · 🇰🇷 South Korea

Compare

1,510,000

-0.40%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Analyst ratings

31 analysts, 1 Feb 2026. The analysts' own views, not ours.

  • 12Strong buy
  • 18Buy
  • 1Hold
  • 0Sell
  • 0Strong sell

Price targets

Brokers' own targets, 1 Feb 2026. Not our view.

Average target 2,266,567.52

Low
2,018,784.8
Average
2,266,567.52
Median
2,244,000
High
2,730,000

Forecasts

Analyst averages for the fiscal years ahead

FY2026FY2027FY2028FY2029FY2030
Revenue₩5.56trn₩6.41trn₩7.17trn₩7.72trn₩8.57trn
Revenue, highest₩5.71trn₩7.20trn₩7.74trn₩8.33trn₩9.25trn
Revenue, lowest₩5.44trn₩6.04trn₩6.87trn₩7.40trn₩8.22trn
Earnings per share39306.4046316.0052321.11——
Earnings per share, highest40188.5454222.5457709.15——
Earnings per share, lowest37737.7541796.6649534.58——
Analysts1923131111

Earnings against forecasts

Earnings per share by fiscal quarter

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Forecast9799.299419.849544.8911295.2110097.007414.786243.464853.86
Reported8448.739314.549924.6610935.4912409.457008.098113.586945.05
Difference-13.8%-1.1%+4.0%-3.2%+22.9%-5.5%+30.0%+43.1%

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

7 / 10

Revenue growth 47.9% a year over 10 years. Return on equity 23.9%.

Model fair value

2,380,100.66

From earnings 2,380,100.66, from revenue 2,391,540.44.

Piotroski score

9 / 9

A nine-point test of financial strength, for 31 Dec 2025.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.